EXPERIENTIAL STRESS RELIEF & ENHANCED COGNITIVE FUNCTION

Similar documents
CSIR Biosciences: Natural Products and Agroprocessing

Adrafinil: A Novel Vigilance Promoting Agent

NERVOUSNESS NEW SCIENCE NEW SOLUTIONS

Adverse effects of caffeine after a single dose and after repeated doses consumed within a day

NOW easily fits that description today as a top-selling brand in health food

ACTELION S NEW DUAL OREXIN RECEPTOR ANTAGONIST

The Effects of Sceletium tortuosum in the Chick Anxiety-Depression Model. by Emily Mae Fountain. Oxford May 2017

Bi-directional Relationship Between Poor Sleep and Work-related Stress: Management through transformational leadership and work organization

A Stronger Start to Every Workout

Fang-Chi Chang (M.D.,Ph.D.) Center for Drug Evaluation, Taiwan

(+)-3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]-ethyl]- 6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4H-pyridol[1,2-a]pyrimidin-4- one

MULTIPLE CHOICE. Choose the one alternative that best completes the statement or answers the question.

Breathtaking science. Developing respiratory drugs to improve health and quality of life. H.C. Wainwright Global Life Sciences Conference April 2018

Given the present state of

Memory Pharmaceuticals Establishes Plans for Clinical Program for MEM 3454 in Schizophrenia. -Broadens Roche Nicotinic Alpha-7 Alliance-

Antidepressants for treatment of depression.

AXIM Biotechnologies Reports Year End 2017 Results

MAPS Study MP-10 1 Study Synopsis UK April 18, 2011

Preventing Compassion Fatigue and Burnout. Jenn Hannigan MD CCFP(PM) Mar.14, 2017

Living well with and beyond cancer Information, support and practical advice to help you through treatment and beyond

Heart-Based Living. Discover how to live the life you want HeartMath

Dutch Life Sciences November 24 th, Erik Dam, CBO

Licensing of Herbal Medicines from Asia in Germany

The Opportunity: c-ibs and pain relief with confidence YKP10811

THE COMPLETE CBD GUIDE

Postpartum depression is the most common medical complication of childbirth, estimated to affect approximately 400,000 women annually in the U.S.

GEPIC. An Introduction to Guide for the Evaluation of Psychiatric Impairment for Clinicians. Dr Michael Duke Senior Forensic Psychiatrist

Developing Food Derived Compounds for Health The Innovation Process

PLANT-BASED EATING TAKES ROOT Focus on Beverages

DSM-5 MAJOR AND MILD NEUROCOGNITIVE DISORDERS (PAGE 602)

Presenter: Naomi Armitage Author: Naomi Armitage, Gryphon Psychology

Niroga Ayurveda Restore & Balance Body, Mind, & Spirit (949)

Study No: Title : Rationale: Phase: Study Period: Study Design: Centres: Indication: Treatment: Objectives: Statistical Methods: Sample Size

Understanding and improving attention and information processing in MS

WELCOME TO THEORY WELLNESS CUSTOMERS. Committed to wellbeing through cannabis.

Annual Special Education Directors Conference 2013 Leading with the Brain in Mind

Iris Manor, MD. UK Adult ADHD Network 4th Annual Congress London, England September 11, 2014

ADHD in the Preschool Aged Child

Mental Health: Where Nutrition meets Psychiatry By Nicola Walters, Registered Dietitian

DEMENTIA? 45 Million. What is. WHAT IS DEMENTIA Dementia is a disturbance in a group of mental processes including: 70% Dementia is not a disease

Health Canada s Proposed Approach to Managing Caffeinated Energy Drinks

Behavior Outcome D R. H A R R I S L I E B E R M A N

POSITION PAPER - THE MENTAL HEALTH PEER WORKFORCE

Neuropsychological Testing (NPT)

Depression and Bipolar Disorder

WELCOME TO THEORY WELLNESS PATIENTS. Committed to wellbeing through cannabis.

Substance Use Disorders

Request for Letters of Intent. International Development of H5N1 Influenza Vaccines

Stress Transforming Tools that Recharge Your Energy and Accelerate Healing

Mental Illness Awareness Month

Generalized Anxiety Disorder. By, Jennifer Corr

ICCAM platform. Introduction. David Nutt November 2011

Mental Health Rotation Educational Goals & Objectives

GRAS Overview and Industry Perspectives. Janet Balson International Food Additives Council

Philip Burke, PhD 18 Year PSC Patient Clinical Psychologist

Aging with Bipolar Disorder. Neha Jain, MD, FAPA Assistant Professor of Psychiatry, UConn Health

Functional Assessment of Depression and Anxiety Disorders Relevant to Work Requirements

Cannabinoids and Mental Health

Future nutrition : can stress models help to achieve personalized nutrition?

VCE Health and Human Development

BAPTIST HEALTH SCHOOL OF NURSING NSG 3036A: PSYCHIATRIC-MENTAL HEALTH

10 Facts We All Need to Know About Dementia (MNCD) in Old Age

SLENDESTA. NORTH AMERICA TOLL FREE ASIA +81 (0) EUROPE

CADE Clinic. Mapping Teenage Minds 19/11/2013. Professor Gin S. Malhi. 21 st Century Medicine Series. Sydney Medical School

Safety Assessment of Botanicals and Botanical Preparations. Dr. Balasubramanian

has been proven safe by 3 Toxicity Studies has been affirmed GRAS by an expert panel is certified Organic as per USDA standards

SOUTH AFRICAN HOCKEY ASSOCIATION LONG TERM PARTICIPANTS DEVELOPMENT (LTPD) SUMMARY GUIDE

The Better Health News2

Week 2: Disorders of Childhood

Agmaset and AgmaVet TM

Bio11: The Nervous System. The human brain. fmri scans of the brain a tool for brain mapping. MRI image of the head. Neurons carry electrical signals

CURRICULUM VITAE Michelle M. Manasseri, M.A., M.S.

HIBBING COMMUNITY COLLEGE COURSE OUTLINE

substance use and mental disorders: one, the other, or both?

Supplier Code of Business Conduct

Overview. Classification, Assessment, and Treatment of Childhood Disorders. Criteria for a Good Classification System

Bipolar Disorder WHAT IS BIPOLAR DISORDER DIFFERENT TYPES OF BIPOLAR DISORDER CAUSES OF BIPOLAR DISORDER WHO GETS BIPOLAR DISORDER?

SECTION 1. Children and Adolescents with Depressive Disorder: Summary of Findings. from the Literature and Clinical Consultation in Ontario

Healthy Habits for Sleeping

Therapeutic Benefits of Caregiver Interventions

Memree. Supports Cognitive Function and Stress Reduction. Memree. Nutrition

PLAN FOR TODAY. What is Emotional Intelligence/EQ? Why it Matters An Overview of the EQ Model Lots of ideas for improving your EQ

New learning techniques in adults recruited from Memory Assessment Service clinics:

Mental Health America of Eastern Missouri

CRITICALLY APPRAISED PAPER (CAP)

Anne Power. Wellness at Work Co-ordinator

MINDFULNESS & EDUCATION. Davis Behavioral Health

E-BOOK MEDICAL CAUSES OF BIPOLAR DISORDER

Investor Presentation

The Three-Factor Theory of Personality. David Center. There has been a plethora of theories of personality and measures of

Having memory problems? Trouble thinking clearly? If this sounds like you, or someone you know, please consider the ENGAGE Study. Patient Information

Mindfulness-Based Stress Reduction

Report on the Ontario Principals Council Leadership Study. Executive Summary

Workplace stress in South African mineworkers

PREMIUM WHOLE-PLANT CANNABINOID HEMP EXTRACT CHARLOTTE S WEB. by the Stanley Brothers. Science Driven. Naturally Crafted. Family Trusted. cwhemp.

Term Paper: Ginkgo Biloba s Influence on Memory and Cognition

ewellness magazine 7 Steps to keeping your body healthy Steps to keeping your body

Coping with Alzheimer s Disease in the Internet Age Survey Results

12 The biology of love

Transcription:

EXPERIENTIAL STRESS RELIEF & ENHANCED COGNITIVE FUNCTION

TABLE OF CONTENTS Presentation Overview OVERVIEW Highlights Safety SCIENTIFIC EVALUATION Clinical Efficacy Effects on Cognitive Function,, Stress Reduction & Mood Enhancement Mechanism of Action SOCIAL RESPONSIBILITY Vertical Integration Socially Responsible REGULATORY & TECHNICAL Regulatory Status Product Application 2

ZEMBRIN OVERVIEW & BACKGROUND 3

HIGHLIGHTS Landmark Achievements Clinically evaluated for safety & efficacy Supported by >300 years of indigenous use Patented Standardized & vertically integrated from seed to extract Self-affirmed GRAS Ecologically & socially responsible No withdrawal effects 4

OVERVIEW Zembrin - an Exclusive Selection of Sceletium Unique selection of the South African plant Sceletium that is rich in mesembrenone, and low in mesembrine developed into a proprietary, standardized extract, trade marketed as All studies, safety data, claims, patents, bioprospecting permits and export permits are related to the proprietary standardized extract and is not applicable to other forms of Sceletium 5

SCELETIUM EFFICACY Origins of Sceletium Use For Mood, Stress, Cognitive Health Indigenous Use Use documented as early as 16 th century Currently used for physical and emotional stress and to induce wellbeing In vivo Animal Studies Decreased excessive barking in dogs Decreased cage and travel stress in cats Improved dementia in dogs and cats Published Clinical Case Studies* Reports of improved mood, anxiety, energy & focus Patients with major depression, anxiety or personality disorder *Gericke, N. Clinical application of selected South African medicinal plants. Australian Journal of Medical Herbalism 2001 (13) 3 17. 6

SAFETY Confirmed by a Full Array of Safety & Toxicity Evaluations PUBLISHED CLINICAL SAFETY STUDY 1 : A RCT evaluation of 25mg of Zembrin in 36 healthy adult volunteers over a 12 week period Zembrin was safe and well tolerated PUBLISHED IN VIVO SAFETY STUDIES 2 : No chronic toxicity (90 day study) at 600 mg/kg per day No acute toxicity (14 day study) at 5000 mg/kg IN VITRO: No toxicity; Ames test, Micronucleus, herg 1 Nell et al (2013) A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Trial of Extract Sceletium tortuosum (Zembrin) in Healthy Adults. J Alt Compl Medicine 18:1-7 2 Murbach et al (2014) A toxicological safety assessment of a standardized extract of Sceletium tortuosum (Zembrin) in rats Food and Chemical Toxicology 74:190-199 7

SCIENTIFIC EVALUATION WEIGHT MANAGEMENT CLINICAL SAFETY & EFFICACY STUDIES 8

CLINICAL EFFICACY 3 Clinical Trials Conducted with Zembrin 1 Terburg D et al. 2013 Acute Effects of Sceletium tortuosum (Zembrin), a Dual 5-HT Reuptake and PDE4 Inhibitor, in the Human Amygdala and its Connection to the Hypothalamus. Neuropsychopharmacology 1-9 2 Chiu et al. 2014 Proof-of-Concept Randomized Controlled Study of Cognition Effects of the Proprietary Extract Sceletium tortuosum (Zembrin) Targeting Phosphodiesterase-4 in Cognitively Healthy Subjects: Implications for Alzheimer s Dementia Evidence-Based Complementary and Alternative Medicine 3 Nell et al. 2013 A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Trial of Extract Sceletium tortuosum (Zembrin) in Healthy Adults. J Altern Compl Med 18:1-7. Functional MRI, Anxiolytic (Terburg et al, 2013) 1 Cognitive Function (Chiu et al, 2014) 2 Safety & Tolerability (Nell et al, 2013) 3 9

PUBLISHED PHASE 1 SAFETY STUDY Clinical evaluation for 12 weeks demonstrates safety in humans STUDY DESIGN Objective: To evaluate safety and tolerability of Zembrin at two levels of intake (8 mg/d or 25 mg/d) Randomized, double-blind, placebo controlled clinical trial 37 healthy volunteers, age 18-55 years old PHASE 1 SAFETY STUDY ZEMBRIN SHOWN TO BE WELL-TOLERATED No differences among the 3 treatment groups in vital signs, ECG, body weight and physical exam between baseline and end of study. Unsolicited positive effects on wellbeing were noted by some participants taking Zembrin, including improved coping with stress and sleep. Nell et al. 2013 A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Trial of Extract Sceletium tortuosum (Zembrin) in Healthy Adults. J Altern Compl Med 18:1-7. 10

EFFECTS ON COGNITIVE FUNCTION Clinical Trial Details Chiu et al. 2014 STUDY SITE University of Western Ontario, Canada PI: Dr. Simon Chiu Clinical Investigator: Dr. Michael Woodbury DOUBLE-BLIND, PLACEBO- CONTROLLED CROSSOVER STUDY 21 volunteers (male and female), mean age 54.6 + 6 years 25 mg of Zembrin or placebo daily Healthy Population: No DSM IV-R cognitive or mood disorders COGNITION MOOD PSYCHOMOTOR FUNCTION Chiu et al. 2014 Proof-of-Concept Randomized Controlled Study of Cognition Effects of the Proprietary Extract Sceletium tortuosum (Zembrin) Targeting Phosphodiesterase-4 in Cognitively Healthy Subjects: Implications for Alzheimer s Dementia Evidence-Based Complementary and Alternative Medicine 11

COGNITIVE FUNCTION Clinical Study Design Chiu et al 3 Weeks Active/Placebo 3 Weeks Washout PARAMETERS EVALUATED Primary: Cognitive Function (CNS VitalSign battery of tests)* Secondary: Mood: Hamilton Depression Rating Scale (HAM-D) Safety & Tolerability *CNS VitalSign has been used for testing neurocognitive function by over 5000 clinicians in 52 countries 3 Weeks Placebo/Active Chiu, et al. 2014 12

COGNITIVE FUNCTION Zembrin Significantly Improved Key Cognitive Domains COGNITIVE FLEXIBILITY Ability to shift attention between two or more tasks and the ability to adapt to rapidly changing directions and intelligently utilize the information. Necessary for decision-making, impulse control and strategy formation. CNS VitalSign has been used for testing neurocognitive function by over 5000 clinicians in 52 countries mean percentiles Cognitive Set Flexibility 35.4 Baseline *p < 0.022 vs. placebo 60.2 * Zembrin 3 weeks 49.7 Placebo 13

COGNITIVE FUNCTION Zembrin Significantly Improved Key Cognitive Domains EXECUTIVE FUNCTION Refers to exercising initiative, proper judgment, discipline and the ability to operate in favor of an abstract reward. Spontaneous ability to take action and goal-directed behavior. Chiu et al. 2014 CNS VitalSign has been used for testing neurocognitive function by over 5000 clinicians in 52 countries mean percentiles 36.8 *p < 0.032 vs. placebo Executive Function Baseline 60.8 * Zembrin 3 weeks 50.1 Placebo 14

COGNITIVE IMPROVEMENTS Stress Reduction & Mood Enhancement HAM-D SCORE Gold-Standard to assess severity of depression and response to therapy in clinical research RESULTS Reduction of stress and improvement of mood manifested through: Statistically significant improved quality of sleep Less fatigue Enhanced work performance Enhanced interest in daily activities Less irritability, worry and insecurity Chiu et al. 2014 Reduction of HAM-D Scores from baseline (%) 26.9% (p<0.075) Zembrin 13.8% (p<0.289) Placebo 15

STRESS MANAGEMENT Functional MRI (fmri) Evaluation Terburg et al, 2013 STUDY SITE University of Cape Town, South Africa Investigators: Drs. David Terburg, Dan Stein and Jack van Honk DOUBLE-BLIND, PLACEBO-CONTROLLED CROSSOVER STUDY 16 volunteers (male and female), 18 21 years 25 mg of Zembrin or placebo single dose Healthy Population: healthy undergraduate students, no history of neurological or psychopathology 16

STRESS MANAGEMENT Crossover Clinical Study Design DESIGN 1 dose of Zembrin or Placebo MRI Scan 5 8 days Washout PARAMETERS EVALUATED Activation and Response of the brain to threat/stress via: Perpetual-load test Emotion-masking task 1 dose of Zembrin or Placebo MRI Scan Terburg D et al. 2013 Acute Effects of Sceletium tortuosum (Zembrin), a Dual 5-HT Reuptake and PDE4 Inhibitor, in the Human Amygdala and its Connection to the Hypothalamus. Neuropsychopharmacology 1-9 17

STRESS MANAGEMENT fmri Study Results Show Reduced Stress Response ZEMBRIN MAY HELP IN THE MANAGEMENT OF STRESS IN EVERYDAY LIFE A single dose of Zembrin attenuates reactivity within the part of the brain (amygdala) that responds to threat/stress Terburg, et al (2013) 18

MECHANISM OF ACTION Working Hypotheses 1) PDE-4 INHIBITION Increases intracellular camp camp / cgmp regulation critical in memory-related processes Cognitive Function Neuroprotection Depression Alzheimer s Inflammation 2) INHIBITS 5-HT REUPTAKE Anxiolytic effect of SRI Stress negatively affects cognitive function DUAL EFFECT OF 2 ACTIVITIES (5-HT REUPTAKE AND PDE-4 INHIBITION) WORKING SYNERGISTICALLY 19

SOCIAL RESPONSIBILITY SUSTAINABLY & SOCIALLY DEVELOPED 20

1.5e6 1.0e6 0.5e6 VERTICAL INTEGRATION Zembrin Elite Plant Propagation and Production [AV1243_SC] TIC #1 5.00 7.50 10.00 12.50 15.00 17.50 20.00 22.50 21

SOCIALLY RESPONSIBLE Ecologically Sustainable 1st ever export permit from South African government, full compliance under the Biodiversity Act International best practice benefit-sharing agreement with South African San Council Endorsement by indigenous people with the exclusive use of their trademark for a Sceletium product Biodiversity leadership hailed at UN Nagoya conference by Minister of the Environment Ecologically sustainable plant production & cultivation, to EU and Global GAP Reliable supply chain and validated QC through own propagation & production 22

REGULATORY & TECHNICAL PRODUCT APPLICATION EXAMPLE 23

REGULATORY AND IP STATUS Safety Data Supports Food & Supplement Use DIETARY SUPPLEMENTS Historical use NDI on-file at 25 mg / day FOOD Self-Affirmation GRAS IP STATUS US patent # 6,288,104 US patent # 8,552,051 US patent # 8,980,338 PCT/IB2010/051132 (pending) 24

PRODUCT APPLICATION - EXAMPLE The Energy Drink Reinvented Growing Consumer Concern about Mental Energy & Focus 39% % ex/v concerned 53% 2000 2010 Source: 2010 HealthFocus International Increasing Dependence on Foods & Beverages for Help 14% 21% 2000 2010 Always/Usually Choose Foods & Beverages to Improve Mental Performance 25

PRODUCT APPLICATION - EXAMPLE Mental Energy Drink Convergence of evidence supports use of Sceletium tortuosum for multiple benefits: Cognitive Function Focus Improved Mood Reduced Stress Mental Energy Drink for Calm Focus Caffeine- Free 26

OUR CORE VALUES MAKE US BETTER PARTNERS BENEFICIAL AND FAIR TO ALL HIGH COMMITMENT CULTURE INTEGRITY CREATIVITY ECSTATIC CUSTOMERS